Description
Decvadol (Dequalinium Chloride) Lozenges №30
Ingredients
Active ingredient: Dequalinium chloride. Other ingredients may include sucrose, glucose, and flavors.
Mechanism of Action
Pharmacological Properties: Dequalinium chloride exerts its action by disrupting the cell membrane of microorganisms, leading to their death. This mechanism of action helps in combating infections in the throat and mouth effectively.
Indications for Use
Indications: Decvadol lozenges are indicated for the relief of sore throat and mouth infections.
Contraindications
Contraindications: Do not use if allergic to dequalinium chloride or any other ingredients in the product. Consult a healthcare professional before use if pregnant or breastfeeding.
Side Effects
Common side effects may include a temporary numbness of the tongue or mouth. If any unusual or severe side effects occur, discontinue use and seek medical advice.
Usage Instructions
Directions: Place the lozenge in the mouth and allow it to dissolve slowly without chewing. Avoid eating or drinking for at least 30 minutes after using the lozenge.
Dosage: Adults and children over 6 years: Dissolve one lozenge slowly in the mouth every 2-3 hours as needed. Do not exceed 8 lozenges in 24 hours.
Benefits Compared to Analogues
Decvadol lozenges offer a potent antimicrobial effect against a broad spectrum of pathogens, providing rapid relief from throat infections and sore throat symptoms. The efficacy of dequalinium chloride in inhibiting microbial growth sets it apart from traditional lozenges.
Suitable Patient Groups
Decvadol lozenges are suitable for both children and adults over 6 years of age. The dosage can be adjusted for elderly patients based on individual health conditions.
Storage and Shelf Life
Store Decvadol lozenges in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use the product if expired.
Packaging Description
Decvadol lozenges are available in a pack containing 30 individually wrapped lozenges for convenient and hygienic use.
Clinical Evidence and Proven Effectiveness
Scientific Evidence: Dequalinium chloride, the active ingredient in Decvadol lozenges, has demonstrated antimicrobial properties against a wide range of bacteria and fungi. Studies have shown its effectiveness in reducing the symptoms of throat infections and providing relief from sore throat. Research published in the Journal of Antimicrobial Chemotherapy highlighted the efficacy of dequalinium chloride in inhibiting the growth of various pathogens commonly associated with throat infections.
Clinical Trials: Clinical trials have shown that Decvadol lozenges provide rapid relief from sore throat symptoms and aid in the resolution of mouth infections. Patients reported a significant reduction in pain and inflammation after using the lozenges as directed.
